Menu

BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call Transcript
📰

BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·15 days ago
#3eLBJ3Cz
#seekingalpha#research#biomarin#call#gaap
Reading 0:00
15s threshold

BioMarin Pharmaceutical Inc. ( BMRN ) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST

Company Participants

Traci McCarty - Group Vice President

Alexander Hardy - President, CEO & Director

Cristin Hubbard - Executive VP & Chief Commercial Officer

Gregory Friberg - Executive VP and Chief Research & Development Officer

Brian Mueller - CFO & Executive VP of Finance

Conference Call Participants

Sean Laaman - Morgan Stanley, Research Division

Eliana Merle - Barclays Bank PLC, Research Division

Adithya Jayaraman - Evercore Inc.

Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division

Alexandria Hammond - Wolfe Research, LLC

Rakesh Kumar

Joon Lee

Olivia Brayer - Cantor Fitzgerald & Co., Research Division

Christopher Raymond - Raymond James & Associates, Inc., Research Division

Joseph Schwartz - Leerink Partners LLC, Research Division

Presentation

Operator

Hello, everyone. Thank you for joining us, and welcome to the BioMarin Third Quarter 2026 Conference Call.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.